NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-EB-21-011 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-21-032 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute will support a Coordinating Center (CC) to facilitate coordination across the new Exercise and Medical nutrition Interventions to Improve Cancer Treatment-related Outcomes awardee sites (see U01 awards supported under companion RFA-CA-21-031). This CC will support three to five anticipated cooperative agreement (U01) project sites focused on the conduct of exercise and medical nutrition clinical trials to improve cancer treatment-related outcomes. The CCs primary mission will include collaborative scientific contribution and entail administrative and communication responsibilities. The activities and responsibilities include, but are not limited to, fostering collaboration among transdisciplinary scientific teams across U01 research sites, facilitating identification and collection of common data across U01 sites for use in pilot projects, participating in cross U01 site pilot projects, and leading data analyses, exploring opportunity for novel data collection, examining common research questions across U01 sites, and providing communication and logistical support for annual in-person meetings of the U01 project sites and other cross-site virtual meetings of U01 investigators. The CC will also develop and execute a platform to monitor progress facilitate the evaluation of the initiative across U01 project sites. The awardee will participate in an Exercise and Nutrition to Improve Cancer Treatment-related Outcomes (ENICTO) cooperative agreement consortium.
Funding Opportunity RFA-CA-21-031 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) seeks to support exercise and/or medical nutrition intervention research designed to improve cancer treatment-related outcomes for therapies delivered with curative or life-extending intent to cancer survivors. Projects may include either pediatric or adult cancer patient populations and must identify a treatment-related outcome as a primary endpoint and specify a relevant patient-reported secondary outcome(s). Priority will be given to studies with direct clinical relevance and translational potential. Responsive applications will fill a research gap concerning the efficacy of specific exercise and dietary approaches to improve cancer treatment-related outcomes. Information gained should improve behavioral intervention protocols for cancer survivors undergoing cancer treatment and may also generate feasibility information concerning translation into clinical care. Awardees will participate in an Exercise and Nutrition to Improve Cancer Treatment-related Outcomes (ENICTO) in Cancer Survivors Consortium.
Notice NOT-ES-21-006 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-006 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-003 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-226 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Technology Transfer (STTR) projects to develop novel tools and devices to improve handling of laboratory animals, to ease the management of animal facilities, and to enhance experiments which use animal models. The intent is to facilitate the design, implementation, and creation of tools and devices to directly benefit the welfare of research animals, and to advance equipment to improve infrastructure and environmental conditions of animal facilities that support biomedical and bio-behavioral research.
Funding Opportunity PAR-21-225 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR) projects to develop novel tools and devices to improve handling of laboratory animals, to ease the management of animal facilities, and to enhance experiments which use animal models. The intent is to facilitate the design, implementation, and creation of tools and devices to directly benefit the welfare of research animals, and to advance equipment to improve infrastructure and environmental conditions of animal facilities that support biomedical and bio-behavioral research.
Funding Opportunity RFA-DE-22-002 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to support research on how to optimally address upstream social determinants of health that can often present a barrier to optimal oral health and impede the effectiveness of clinical interventions, particularly in vulnerable and underserved communities. To achieve this goal, this initiative will encourage multi-disciplinary collaborations, mechanistic research, multi-level research, and the use of complex systems science approaches.
Notice NOT-HS-21-014 from the NIH Guide for Grants and Contracts
Notice NOT-NS-21-059 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-21-023 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences Mentoring Activities The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce. NIDDK's Short-Term Research Experience for Underrepresented Persons (STEP-UP) provides funding to research institutions to provide for a national summer research experience program for both high school and undergraduate students for eight to ten weeks. STEP-UP seeks to facilitate exposure opportunities for students from diverse backgrounds underrepresented in biomedical research on a national basis, including individuals from disadvantaged backgrounds, individuals from underrepresented racial and ethnic groups, and individuals with disabilities.
Notice NOT-AI-21-049 from the NIH Guide for Grants and Contracts
Notice NOT-TR-21-026 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-064 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-063 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-110 from the NIH Guide for Grants and Contracts
Notice NOT-AG-21-022 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-21-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical study to collect safety and effectiveness data required to support a marketing application or to inform final device design.
Funding Opportunity RFA-NS-21-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.